Showing results (601-610 of 696) with videos related to

Sort By:
Pageof 70
Carcinogenesis|June 28, 2013
Comparative benefits of Nab-paclitaxel over gemcitabine or polysorbate-based docetaxel in experimental pancreatic cancerNiranjan Awasthi, Changhua Zhang, Anna M Schwarz, et al.
Hepato-Gastroenterology|March 14, 2014
Evaluation of skeletonization of the hepatoduodenal ligament for the lower third gastric cancer by propensity score analysisZhe-Wei Wei, Guang-Kai Xia, Ying Wu, et al.
World Journal of Gastroenterology|June 8, 2013
Efficacy of adjuvant XELOX and FOLFOX6 chemotherapy after D2 dissection for gastric cancerYing Wu, Zhe-Wei Wei, Yu-Long He, et al.
Digestive Diseases and Sciences|December 10, 2013
Impact of pre-existing type-2 diabetes on patient outcomes after radical resection for gastric cancer: a retrospective cohort studyZhe-Wei Wei, Jia-Ling Li, Ying Wu, et al.
Aging Cell|January 11, 2024
Age-regulated cycling metabolites are relevant for behaviorJessica E Schwarz, Arjun Sengupta, Camilo Guevara, et al.
Molecular Cancer Therapeutics|May 2, 2022
Augmenting Experimental Gastric Cancer Activity of Irinotecan through Liposomal Formulation and Antiangiogenic Combination TherapyNiranjan Awasthi, Margaret A Schwarz, Changhua Zhang, et al.
Diabetes Research and Clinical Practice|March 20, 2023
Circulating levels of gastrointestinal hormones in prediabetes reversing to normoglycemia or progressing to diabetes in a year-A cross-sectional and prospective analysisCarlotta Hoffmann, Peter E Schwarz, Christos S Mantzoros, et al.
Annals of Surgical Oncology|November 4, 2010
Phase I dose-escalation study of stereotactic body radiotherapy in patients with hepatic metastasesWilliam Rule, Robert Timmerman, Liyue Tong, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 21, 2012
Presentation, treatment, and clinical outcomes of patients with hepatocellular carcinoma, with and without human immunodeficiency virus infectionAdam C Yopp, Madhu Subramanian, Mamta K Jain, et al.
Journal of Cellular and Molecular Medicine|May 3, 2021
Targeted dual inhibition of c-Met/VEGFR2 signalling by foretinib improves antitumour effects of nanoparticle paclitaxel in gastric cancer modelsMeghan Grojean, Margaret A Schwarz, Johann R Schwarz, et al.
Pageof 70